Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000190082 | SCV000243757 | likely benign | not specified | 2017-10-13 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Sema4, |
RCV002257484 | SCV002533358 | uncertain significance | Hereditary cancer-predisposing syndrome | 2021-08-06 | criteria provided, single submitter | curation | |
Prevention |
RCV004530085 | SCV004117407 | uncertain significance | TSC2-related disorder | 2024-01-26 | no assertion criteria provided | clinical testing | The TSC2 c.-30+2T>C variant is located in the 5' untranslated region. To our knowledge, this variant has not been reported in the literature. This variant is reported in 2 of ~31,000 alleles in gnomAD. This variant has conflicting interpretations of uncertain significance and likely benign in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/207788/). An adjacent nucleotide change has been reported in an individual from an epilepsy and neurodevelopmental disorder cohort study (c.-30+1G>C, Table S4, Lindy et al. 2018. PubMed ID: 29655203). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |